These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 22842615

  • 1. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB.
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS.
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK, Andres JM, Jolley CD, Novak DA, Haafiz AB, González-Peralta RP.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M.
    Acta Gastroenterol Belg; 2009 Oct; 72(3):301-5. PubMed ID: 19902862
    [Abstract] [Full Text] [Related]

  • 14. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
    Lawrance IC, Murray K, Hall A, Sung JJ, Leong R.
    Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
    [Abstract] [Full Text] [Related]

  • 15. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD, Litwin CM, Hill HR.
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [Abstract] [Full Text] [Related]

  • 16. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Torres J, Petralia F, Sato T, Wang P, Telesco SE, Choung RS, Strauss R, Li XJ, Laird RM, Gutierrez RL, Porter CK, Plevy S, Princen F, Murray JA, Riddle MS, Colombel JF.
    Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
    [Abstract] [Full Text] [Related]

  • 17. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [Abstract] [Full Text] [Related]

  • 18. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S, Luo J, Li J, Wu Z, Hu C, Li P, Deng C, Zhang F, Qian J, Li Y.
    Clin Chem Lab Med; 2017 May 01; 55(6):865-875. PubMed ID: 27831916
    [Abstract] [Full Text] [Related]

  • 19. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K, Joossens M, Pierik MJ, Jonkers D, Bohr J, Joossens S, Romberg-Camps M, Nyhlin N, Wickbom A, Rutgeerts PJ, Tysk C, Bodin L, Colombel JF, Vermeire S, Halfvarson J.
    J Crohns Colitis; 2016 Jun 01; 10(6):695-702. PubMed ID: 26818662
    [Abstract] [Full Text] [Related]

  • 20. Serum antibodies associated with complex inflammatory bowel disease.
    Elkadri AA, Stempak JM, Walters TD, Lal S, Griffiths AM, Steinhart AH, Silverberg MS.
    Inflamm Bowel Dis; 2013 Jun 01; 19(7):1499-505. PubMed ID: 23702714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.